44 min listen
The Role of SGLT2 Inhibitors in HFrEF Care: What Do the Latest Clinical Practice Documents Say?
FromKeeping Current
The Role of SGLT2 Inhibitors in HFrEF Care: What Do the Latest Clinical Practice Documents Say?
FromKeeping Current
ratings:
Length:
35 minutes
Released:
Jun 21, 2021
Format:
Podcast episode
Description
Drs Zieroth, Coats, and Januzzi discuss the latest recommendations regarding SGLT2 inhibitors in HFrEF management. Credit available for this activity expires: [06/18/22] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/953116?src=mkm_podcast_addon_953116
Released:
Jun 21, 2021
Format:
Podcast episode
Titles in the series (100)
The Progressive Phenotype of Non-IPF ILD: Clinical Relevance and Identification: Join Dr. Kolb and colleagues covering the etiology, pathophysiology, monitoring, and emerging treatments for non-IPF progressive fibrosing ILDs --- Full URLs: Learning Objectives & Disclosures:... by Keeping Current